SCHEMBL6415151

SCHEMBL6415151

CCOC(=O)c1cc(Br)nn1-c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.56
PDE4D Q08499 1/20 0.56
TP53 P04637 1/20 0.52
ALOX12 P18054 1/20 0.52
ALDH1A1 P00352 6/20 0.52
KDM4E B2RXH2 2/20 0.52
HPGD P15428 2/20 0.52
HSD17B10 Q99714 1/20 0.52
KMT2A Q03164 2/20 0.52
GAA P10253 1/20 0.52
POLB P06746 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.50
RECQL P46063 1/20 0.50
ADORA2A P29274 1/20 0.50
ADORA1 P30542 1/20 0.50
MAPT P10636 2/20 0.49
FAAH O00519 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15520448 0.89 ALDH1A1 (0.60) LMNAPDE4DALOX12ALDH1A1KDM4E
SCHEMBL6420806 0.89 ALDH1A1 (0.51) LMNAPDE4DALDH1A1KMT2APOLB
SCHEMBL28650933 0.86 THRB (0.49) LMNAPDE4DTP53ALDH1A1KDM4E
SCHEMBL6422295 0.86 KMT2A (0.65) LMNAPDE4DTP53ALOX12ALDH1A1
SCHEMBL16112407 0.84 SMN1; SMN2 (0.59) LMNATP53ALDH1A1KDM4EHPGD
SCHEMBL6415533 0.84 LMNA (0.54) LMNAPDE4DTP53ALOX12ALDH1A1
SCHEMBL4981925 0.83 LMNA (0.56) LMNAPDE4DTP53ALOX12ALDH1A1
SCHEMBL22896894 0.83 LMNA (0.56) LMNAPDE4DTP53ALOX12ALDH1A1
SCHEMBL19475586 0.83 ALDH1A1 (0.59) LMNAPDE4DTP53ALOX12ALDH1A1
SCHEMBL6414140 0.83 ALDH1A1 (0.53) LMNAPDE4DTP53ALOX12ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050130989-A1 N-arylheteroaromatic products compositions containing them and use thereof AVENTIS PHARMA S. A. (FR) 2005-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050130989-A1 N-arylheteroaromatic products compositions containing them and use thereof AHR, NQO1, ARNT LMNA 2233/4885PDE4D 3227/4885TP53 79/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.